Those people who are African American especially.

In this study, 11 % of babies born at 22 weeks gestation or much less survived, compared to 27 % at 23 weeks gestation. Survival prices reached 85 % at 28 weeks gestation. Also, about 60 % of the ELBW babies, those that weighed two pounds or less, survived. The study also found that incredibly premature baby women were 1.7 times much more likely to survive than baby males. However, African-American baby young ladies were 2.1 instances as more likely to survive as white boys. The scholarly study only reported on infant mortality. Quality of life or other outcomes, such as complications of the developing brain or lungs, were not assessed. The study, led by Steven B. Morse, MD, MPH, of the University of Florida, looked at the one-year survival rate of 5,076 ELBW babies born in Florida between 1996 and 2000.The IMPRESS study was made to compare the safety and efficacy of continuing IRESSA, combined with cisplatin and pemetrexed up to six cycles , versus comparator placebo, coupled with cisplatin and pemetrexed up to six cycles following development of resistance to first line treatment gefitinib. The study did not meet up with its primary endpoint of a substantial improvement in PFS statistically. The secondary endpoint of overall survival continues to be ongoing.